Therapy News and Research

RSS

How Can CPNs Revolutionize Medical Diagnostics?

At MEDICA 2022, NewsMedical spoke with Andy Chaloner about Stream Bio's conjugated polymer nanoparticle technologies that have the potential to revolutionize the medical and life sciences sectors, from diagnostics to clinical imaging.

From Stream Bio 25 Nov 2022

New CRISPR-based tool can snip out faulty genes and replace them with new ones

Building on the CRISPR gene-editing system, MIT researchers have designed a new tool that can snip out faulty genes and replace them with new ones, in a safer and more efficient way.

24 Nov 2022

Novel cancer-fighting nanoparticles co-deliver a chemotherapy drug and immunotherapy

University of Pittsburgh researchers have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy, according to a new Nature Nanotechnology study published today.

24 Nov 2022

Researchers discover how phage resistance helps drive the emergence of dominant Salmonella strains

Researchers from the Quadram Institute and the University of East Anglia have uncovered how resistance has helped drive the emergence of dominant strains of Salmonella.

24 Nov 2022

World Antimicrobial Awareness Week 2022: What is the burden of antimicrobial resistance?

As part of World Antimicrobial Resistance Week 2022, News-Medical speaks to Dr. Tomislav Meštrović about his new research discussing the burden of bacterial antimicrobial resistance in the WHO European region, as well as about how we can prevent antimicrobial resistance together.

24 Nov 2022

Newly developed healthcare app can help reduce body weight

Behavior therapy is a well-known and effective treatment for obesity. But now, researchers from Japan have found that behavior therapy can be successfully implemented using a smartphone healthcare app.

24 Nov 2022

Study demonstrates that Paxlovid protects severe COVID-19–associated outcomes among persons for whom it is recommended

Researchers assessed the association between receiving a prescription for Paxlovid and COVID-19-related hospitalization in the ensuing 30 days.

24 Nov 2022

Biologic therapy for IBD patients through a financial assistance program could have superior outcomes

Patients with inflammatory bowel diseases (IBD) who required treatment with biologic therapies and were enrolled in a financial assistance program were less likely to need surgery after starting medication than those not enrolled in a program, a study by UT Southwestern researchers found.

23 Nov 2022

New study points to a strategy for inhibiting hyper-progression of melanoma

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

23 Nov 2022

High-risk stage III-IV melanoma patients treated with pembrolizumab report better quality of life

Patients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than patients who received the previous standard-of-care treatment with either ipilimumab or high-dose interferon.

23 Nov 2022

Vitamin D appears to have no substantial impact on statin-related muscle pain

Patients who take statins to lower high cholesterol levels often complain of muscle pains, which can lead them to stop taking the highly effective medication and put them at greater risk of heart attack or stroke.

23 Nov 2022

Single drug compound may offer a promising new strategy for treating prostate cancer patients

A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells.

23 Nov 2022

CAR T therapy extends its reach beyond oncology

Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers.

23 Nov 2022

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

Sartorius BIA Separations (BIA), a leading bio-chromatography company, now part of the international life science group Sartorius, and Exopharm Ltd. (ASX:EX1), a company at the forefront of transformative medicines using exosomes, or extracellular vesicles (EVs), today announced they had entered into a formal collaboration.

From Sartorius 23 Nov 2022

New family of adeno-associated viral vectors found to be better at delivering genetic cargo

Gene therapies can treat, even potentially cure, certain genetic diseases, but it is challenging to deliver the treatments to the parts of the body where they are needed.

22 Nov 2022

Scientists move a step closer to advancing personalized cancer treatment

In a step likely to advance personalized cancer treatment, scientists have for the first time shown in patients that levels of biomarkers are not enough to tell which patients are likely to respond best to immunotherapy.

22 Nov 2022

Study shows how HIV protein permanently alters immune cells

Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation.

22 Nov 2022

Discovery could lead to new mantle cell lymphoma drugs

A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, such that blocking its activity with an experimental drug dramatically slows the growth of this lymphoma in preclinical tests, according to a study from Weill Cornell Medicine researchers.

22 Nov 2022

Low-dose CT screening improves survival rate of lung cancer patients

Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves the survival rate of cancer patients over a 20-year period, according to a large-scale international study being presented by Mount Sinai researchers at the annual meeting of the Radiological Society of North America.

22 Nov 2022

Alcohol consumption during pregnancy can alter the baby's brain structure

A new MRI study revealed that consumption of alcohol even in low to moderate amounts during pregnancy can change the baby's brain structure and delay brain development.

22 Nov 2022

Therapy News and Research

How Can CPNs Revolutionize Medical Diagnostics?

New CRISPR-based tool can snip out faulty genes and replace them with new ones

Novel cancer-fighting nanoparticles co-deliver a chemotherapy drug and immunotherapy

Researchers discover how phage resistance helps drive the emergence of dominant Salmonella strains

World Antimicrobial Awareness Week 2022: What is the burden of antimicrobial resistance?

Newly developed healthcare app can help reduce body weight

Study demonstrates that Paxlovid protects severe COVID-19–associated outcomes among persons for whom it is recommended

Biologic therapy for IBD patients through a financial assistance program could have superior outcomes

New study points to a strategy for inhibiting hyper-progression of melanoma

High-risk stage III-IV melanoma patients treated with pembrolizumab report better quality of life

Vitamin D appears to have no substantial impact on statin-related muscle pain

Single drug compound may offer a promising new strategy for treating prostate cancer patients

CAR T therapy extends its reach beyond oncology

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

New family of adeno-associated viral vectors found to be better at delivering genetic cargo

Scientists move a step closer to advancing personalized cancer treatment

Study shows how HIV protein permanently alters immune cells

Discovery could lead to new mantle cell lymphoma drugs

Low-dose CT screening improves survival rate of lung cancer patients

Alcohol consumption during pregnancy can alter the baby's brain structure

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News